Table 1

Demographic characteristics of patients stratified by years

2005
(N=7494 (26.5%))
2010
(N=9989 (35.3%))
2015
(N=10 794 (38.2%))
Ptrend
Demographic
Age, year (median, IQR)67.0 (57.0–74.0)68.0 (59.0–75.0)67.0 (59.0–76.0)<0.001
Women (no (weighted %, 95% CI))3001 (38.7 (36.9 to 40.5))4069 (40.2 (39.1 to 41.3))4516 (39.8 (39.0 to 40.5))0.60
Cerebrovascular risk factors (no (weighted %, 95% CI))
Hypertension5310 (70.5 (68.8 to 72.2))7474 (76.7 (75.8 to 77.6))7961 (74.8 (74.2 to 75.5))0.02
Diabetes1466 (22.4 (20.9 to 23.9))2072 (25.1 (24.1 to 26.0))2545 (27.8 (27.1 to 28.5))<0.001
Dyslipidaemia567 (7.4 (6.4 to 8.4))1328 (14.7 (13.9 to 15.4))2109 (23.3 (22.7 to 23.9))<0.001
Atrial fibrillation514 (6.6 (5.7 to 7.5))582 (5.1 (4.6 to 5.6))696 (5.6 (5.3 to 6.0))0.47
Current smoker1024 (13.9 (12.6 to 15.1))1550 (17.5 (16.7 to 18.4))1581 (19.4 (18.7 to 20.0))<0.001
Number of risk factors ≥3552 (7.7 (6.7 to 8.6))1479 (17.1 (16.3 to 17.9))2544 (27.5 (26.8 to 28.1))<0.001
Medical history (no (weighted %, 95% CI))
Stroke1351 (21.2 (19.7 to 22.7))2166 (23.1 (22.2 to 24.1))2738 (29.2 (28.5 to 29.9))<0.001
Coronary heart disease1446 (21.0 (19.5 to 22.5))2009 (23.6 (22.7 to 24.5))2570 (27.0 (26.3 to 27.7))<0.001
Myocardial infarction112 (1.6 (1.2 to 2.1))131 (1.4 (1.2 to 1.7))175 (1.9 (1.6 to 2.1))0.07
Insurance status (no (weighted %, 95% CI))
Urban Employee Basic Medical Insurance1420 (24.6 (23.0 to 26.1))2254 (30.4 (29.4 to 31.4))3186 (33.6 (32.9 to 34.3))<0.001
Urban Resident Basic Medical Insurance0811 (10.7 (10.0 to 11.4))1010 (9.3 (8.9 to 9.8))
New Rural Co-operative Medical Insurance Scheme142 (1.6 (1.1 to 2.0))2234 (18.9 (18.0 to 19.7))4275 (33.4 (32.7 to 34.1))
Self-payment3395 (39.4 (37.6 to 41.2))1583 (15.8 (15.0 to 16.6))914 (8.2 (7.8 to 8.6))
Other2537 (34.5 (32.7 to 36.2))3107 (24.1 (23.2 to 25.1))1409 (15.5 (14.9 to 16.0))
Region (no (weighted %, 95% CI))
Rural3986 (25.6 (24.0 to 27.2))5429 (32.0 (31.0 to 33.0))5867 (34.7 (34.0 to 35.4))<0.001
Urban3508 (74.4 (72.8 to 76.0))4560 (68.0 (67.0 to 69.0))4927 (65.3 (64.6 to 66.0))
Clinical characteristic
Time from symptom onset to admission (days; median (IQR))2.0 (0.0–5.0)2.0 (0.0–6.0)2.0 (0.0–7.0)<0.001
Time from symptom onset to admission (days; no (weighted %, 95% CI))
<12491 (30.7 (29.1 to 32.4))2906 (27.7 (26.7 to 28.6))2873 (26.4 (25.8 to 27.1))
1–73858 (52.1 (50.3 to 53.9))5259 (54.2 (53.1 to 55.3))5825 (53.5 (52.7 to 54.2))
≥81138 (17.2 (15.8 to 18.5))1814 (18.2 (17.3 to 19.0))2088 (20.1 (19.5 to 20.7))
Coma (no (weighted %, 95% CI))214 (2.3 (1.7 to 2.8))175 (1.6 (1.3 to 1.9))158 (1.6 (1.4 to 1.8))0.044
Limb weakness (muscle power 0–4) (no (weighted %, 95% CI))3089 (38.4 (36.6 to 40.2))3633 (34.6 (33.6 to 35.6))3391 (33.2 (32.5 to 34.0))<0.001
Limb weakness (muscle power 0–3) (no (weighted %, 95% CI))1984 (24.0 (22.4 to 25.5))2179 (19.5 (18.6 to 20.3))1873 (17.4 (16.9 to 18.0))<0.001
Aphasia or dysarthria (no (weighted %, 95% CI))2031 (29.0 (27.4 to 30.7))2428 (28.8 (27.8 to 29.8))2533 (27.3 (26.6 to 27.9))0.007
Systolic blood pressure (mm Hg; mean (SD))150.2±16.2148.3±22.1145.6±28.8<0.001
Cholesterol (mmol/L; median (IQR))4.8 (4.1–5.5)4.7 (4.0–5.5)4.6 (3.8–5.3)<0.001
Low-density lipoprotein (mmol/L; median (IQR))2.9 (2.3–3.4)2.8 (2.2–3.4)2.6 (2.1–3.3)<0.001
Fast glucose (mmol/L; median (IQR))5.5 (4.8–6.8)5.5 (4.8–6.7)5.6 (4.9–6.9)0.022
Uric acid (μmol/L; median (IQR))291.0 (227.0–364.0)294.0 (237.9–363.0)308.2 (248.0–376.9)<0.001
Alanine transaminase (U/L; median (IQR))18.5 (14.0–28.0)18.0 (13.0–26.0)18.0 (13.0–26.0)<0.001
Estimated glomerular filtration rate (mL/(min/1.73 m2))83.0 (65.7–100.0)91.4 (72.0–104.6)95.4 (78.6–107.3)<0.001
≥902000 (40.4 (38.4 to 42.4))4186 (52.4 (51.3 to 53.6))5557 (60.4 (59.6 to 61.2))<0.001
<903386 (59.6 (57.6 to 61.6))4392 (47.6 (46.4 to 48.7))4087 (39.6 (38.8 to 40.4))<0.001
  • Data are presented by weighted mean along with SD (mean±SD) or median along with IQR (median (IQR)) for continuous variables, and unweighted frequency along with weighted % (95% CI) for categorical variables.